Home »
Academic Articles & Research Papers
Showing 20 of 49 academic articles
James C. L. Chow • Medical Sciences
(2024)
Quantum computing (QC) represents a paradigm shift in computational power, offering unique capabilities for addressing complex problems that are infeasible for classical computers. This review paper provides a detailed account of the curren...
OPENALEX
cc-by
DOI: https://doi.org/10.3390/medsci12040067
PMC: 11586987
Yu Zhang, Peter Tiňo B, Aleš Leonardis, Ke Tang • IEEE Transactions on Emerging Topics in Computational Intelligence
(2021)
Along with the great success of deep neural networks, there is also growing concern about their black-box nature. The interpretability issue affects people's trust on deep learning systems. It is also related to many ethical problems, e.g.,...
OPENALEX
Open Access
DOI: https://doi.org/10.1109/tetci.2021.3100641
Igor I. Baskin, David Alan Winkler, Igor V. Tetko • Expert Opinion on Drug Discovery
(2016)
INTRODUCTION: Neural networks are becoming a very popular method for solving machine learning and artificial intelligence problems. The variety of neural network types and their application to drug discovery requires expert knowledge to cho...
OPENALEX
DOI: https://doi.org/10.1080/17460441.2016.1201262
Günter Klambauer, Thomas Unterthiner, Andreas Mayr, Sepp Hochreiter • arXiv (Cornell University)
(2017)
Deep Learning has revolutionized vision via convolutional neural networks (CNNs) and natural language processing via recurrent neural networks (RNNs). However, success stories of Deep Learning with standard feed-forward neural networks (FNN...
OPENALEX
Open Access
DOI: https://doi.org/10.48550/arxiv.1706.02515
Bernd Jandeleit, Dieter J. Schaefer, Timothy S. Powers, Howard W. Turner et al. • Angewandte Chemie International Edition
(1999)
After forever changing the drug discovery process in the pharmaceutical industry, combinatorial chemistry methodologies are increasingly being applied to the discovery and optimization of more efficient catalysts and materials (see picture)...
OPENALEX
DOI: https://doi.org/10.1002/(sici)1521-3773(19990903)38:17<2494::aid-anie2494>3.0.co;2-#
Raihan Ur Rasool, Hafiz Farooq Ahmad, Wajid Rafique, Adnan Qayyum et al. • Future Internet
(2023)
In recent years, the interdisciplinary field of quantum computing has rapidly developed and garnered substantial interest from both academia and industry due to its ability to process information in fundamentally different ways, leading to ...
OPENALEX
cc-by
DOI: https://doi.org/10.3390/fi15030094
Soumyadeep Ray, Pronaya Bhattacharya, Ebrahim A. Mattar, Abhishek Mukhopadhyay • Computational and Structural Biotechnology Journal
(2025)
This survey examines the convergence of Explainable Artificial Intelligence (XAI) and Quantum Computing (QC) toward precision medicine. We review developments from 2018 to 2025, summarizing quantum algorithms, quantum-machine-learning model...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.csbj.2025.11.031
Luyao Wang, Li Ding, Tianxiang Qin, Xinyu Liu et al. • Toxins
(2026)
Kunitz-type peptides from venomous and blood-sucking animals represent an important natural molecular resource for anticoagulant development towards XIa, a new target for antithrombotic drug discovery. However, the plasmin-inhibitory activi...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/toxins18100449
M. Camila Melo-Narvaez, Fee Gölitz, Eshita Jain, Janine Gote-Schniering et al. • Respiratory Research
(2025)
Abstract Background Human precision-cut lung slices (hPCLS) are a unique platform for functional, mechanistic, and drug discovery studies in the field of respiratory research. However, tissue availability, generation, and cultivation time r...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12931-025-03132-w
Bayram B., Leventi N., Vodenicharova A., Lamprianidou A. et al. • Acta Medica Bulgarica
(2026)
Artificial intelligence (AI) is reshaping healthcare by enhancing diagnostic precision, treatment personalization, and overall patient care. By leveraging technologies such as machine learning, deep learning, natural language processing, an...
DOAJ
Open Access (DOAJ)
DOI: 10.2478/amb-2026-0050
Jinming Zou, Yi Han, Sung‐Sau So • Methods in molecular biology
(2008)
The artificial neural network (ANN), or simply neural network, is a machine learning method evolved from the idea of simulating the human brain. The data explosion in modem drug discovery research requires sophisticated analysis methods to ...
OPENALEX
DOI: https://doi.org/10.1007/978-1-60327-101-1_2
Guoqiang Zhou, Ben Li, Weifeng Zhang, Shudi Bao et al. • BMC Bioinformatics
(2026)
Abstract Efficient prediction of drug-target affinity (DTA) is crucial for accelerating drug discovery. Recently, deep learning approaches leveraging 3D complexes have shown strong potential for drug-target affinity prediction. However, mos...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12859-026-06481-5
Basudev Saha, Bidyut Das, Mukta Majumder • Nanotechnology and Precision Engineering
(2023)
Over the past two decades, digital microfluidic biochips have been in much demand for safety-critical and biomedical applications and increasingly important in point-of-care analysis, drug discovery, and immunoassays, among other areas. How...
DOAJ
Open Access (DOAJ)
DOI: 10.1063/10.0017350
Xinxin Yu, Yimeng Wang, Long Chen, Weihua Li et al. • Journal of Pharmaceutical Analysis
(2025)
Activity cliffs (ACs) are generally defined as pairs of similar compounds that only differ by a minor structural modification but exhibit a large difference in their binding affinity for a given target. ACs offer crucial insights that aid m...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.jpha.2025.101317
Hongming Chen, Ola Engkvist, Yinhai Wang, Marcus Olivecrona et al. • Drug Discovery Today
(2018)
Over the past decade, deep learning has achieved remarkable success in various artificial intelligence research areas. Evolved from the previous research on artificial neural networks, this technology has shown superior performance to other...
OPENALEX
cc-by
DOI: https://doi.org/10.1016/j.drudis.2018.01.039
Erik Gawehn, Jan A. Hiss, Gisbert Schneider • Molecular Informatics
(2015)
Artificial neural networks had their first heyday in molecular informatics and drug discovery approximately two decades ago. Currently, we are witnessing renewed interest in adapting advanced neural network architectures for pharmaceutical ...
OPENALEX
DOI: https://doi.org/10.1002/minf.201501008
Polina Mamoshina, Armando S. Vieira, Eugene Lane, Alex A. Zhavoronkov • Molecular Pharmaceutics
(2016)
Increases in throughput and installed base of biomedical research equipment led to a massive accumulation of -omics data known to be highly variable, high-dimensional, and sourced from multiple often incompatible data platforms. While this ...
OPENALEX
DOI: https://doi.org/10.1021/acs.molpharmaceut.5b00982
Pan A, Zhai T, Lee J, Zheng C et al. • bioRxiv
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.64898/2026.10.14.759026
PMC: PMC13738432
Jörn Lötsch, Alfred Ultsch • Pain
(2017)
1. Introduction Pain and pain chronification are incompletely understood and unresolved medical problems that continue to have a high prevalence.14 It has been accepted that pain is a complex phenomenon.2,32,72 Contemporary methods of compu...
OPENALEX
cc-by-nc-nd
DOI: https://doi.org/10.1097/j.pain.0000000000001118
PMC: 5895117
Jessica J. Vamathevan, Dominic A. Clark, Paul Czodrowski, Ian Dunham et al. • Nature Reviews Drug Discovery
(2019)
OPENALEX
Open Access
DOI: https://doi.org/10.1038/s41573-019-0024-5
PMC: 6552674